University of Oxford
Computational Research Assistant in Cancer Antigen Discovery and Prioritisation
Oxford OX3 7DQ
Key information
- Pay
- £36,360 to £40,178 a year
- Hours
- Full-time
- Contract
- Contract
- Workplace arrangement
- On-site
- Posted date
- 20 Nov 2026
- Closing date
- 27 Nov 2026
About this role
We are seeking a motivated Computational Research Assistant to join the Adamopoulou Group at the Centre for Immuno-Oncology, University of Oxford. You will support research focused on cancer antigen discovery and the development of next-generation vaccines, using large-scale transcriptomic datasets to help identify and prioritise potential cancer antigens.
You will analyse and manage public and in-house bulk and single-cell RNA-sequencing data, performing quality control, normalisation, annotation and interpretation using computational and statistical approaches including R, Python, Seurat and Scanpy. You will also develop and maintain reproducible bioinformatics workflows, troubleshoot analytical challenges and present findings through clear visualisations, reports and presentations.
Working within a multidisciplinary team of immunologists, clinicians, mass-spectrometry experts, data engineers and bioinformaticians, you will help translate complex data into meaningful biological insights. This is an excellent opportunity to develop your bioinformatics expertise while contributing to collaborative research in cancer immunology, antigen discovery and vaccine development.
Applications for this vacancy should be made online and you will need to upload a supporting statement and CV. Your supporting statement must explain how you meet each of the selection criteria for the post using examples of your skills and experience. Please restrict your documentation to your CV and supporting statement only. Any other documents will be requested at a later date.
This position is offered full time on a fixed term contract until 31 May 2027 and is funded GO-Precise, GSK.
Only applications received before 12 midday on Friday, 27 November 2026 will be considered. Please quote 189819 on all correspondence.